Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    H7N9 influenza | Vaccine | NIH
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: Live attenuated H7N9 A/Anhui/13 ca influenza virus vaccine;   Biological: Inactivated subvirion H7N9 influenza vaccine
2 Completed Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: H7N9 A/Anhui/13 ca influenza virus vaccine;   Biological: Inactivated subvirion H7N9 vaccine
3 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
4 Not yet recruiting Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: H7N9 pLAIV;   Biological: H7N9 pIIV;   Biological: AS03 adjuvant
5 Active, not recruiting H7N9 Boost in Healthy Adults
Condition: Influenza
Intervention: Biological: Monovalent influenza A/H7N9 virus vaccine
6 Completed Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)
Condition: Influenza A Virus, H5N1 Subtype
Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine with AS03 adjuvant;   Biological: Influenza A (H5N1) Virus Monovalent Vaccine without AS03 adjuvant
7 Completed Inactivated Influenza A/H5N1 Vaccine in the Elderly
Condition: Influenza
Interventions: Biological: Influenza A/H5N1 Vaccine;   Drug: Placebo
8 Completed H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults
Condition: Influenza
Intervention: Biological: Inactivated Influenza A Vaccine A/H5N1
9 Active, not recruiting Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: H7N9 Anhui 2013/AA ca;   Biological: Inactivated subvirion H7N9 vaccine
10 Completed Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
Condition: Influenza
Intervention: Biological: Influenza A/H5N1
11 Completed Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
Condition: H5N1 Influenza
Intervention: Biological: H5N1 Vaccine
12 Recruiting Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine.
Conditions: Avian Influenza;   H1N1 Influenza;   Influenza
Interventions: Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203;   Biological: Monovalent influenza A/H7N9 virus vaccine
13 Completed A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
Condition: Influenza
Interventions: Biological: Influenza A/H5N1 Vaccine;   Drug: Placebo
14 Completed H7N9 Mix and Match With MF59 in Healthy Elderly Persons
Condition: Avian Influenza
Interventions: Drug: MF59;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
15 Completed H5N1 (Clade 2) Vaccination of Adults and Elderly
Condition: Influenza
Intervention: Biological: Influenza A/H5N1/Indonesia/05/05 (clade 2) inactivated vaccine
16 Completed H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition: Influenza
Interventions: Drug: ASO3 Adjuvant;   Biological: Influenza A/H5N1 Vaccine
17 Completed H7N9 Mix and Match With MF59 in Healthy Adults
Condition: Influenza
Interventions: Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Drug: MF59
18 Completed An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
Condition: Influenza A Virus, H5N1 Subtype
Interventions: Biological: VRC-AVIDNA036-00-VP;   Biological: Monovalent Influenza Subunit Virion (Inactive H5N1) Vaccine
19 Completed St. Jude Open Label H5 Trial
Condition: Influenza
Intervention: Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)
20 Completed H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults
Condition: Influenza
Interventions: Biological: Aluminum hydroxide;   Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.